MedTrace Logo

Far Infrared Therapy on Arteriovenous Fistulas in Hemodialysis Patients

NCT04011072 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 206

Last updated 2024-02-29

No results posted yet for this study

Summary

The number of hemodialysis patients in the world are increasing. In order to receive a sufficient dialysis, the patients needs a well functioning and stable vascular access - preferably an arteriovenous fistula (AVF). Unfortunately, the AVF has a high incidence of stenosis with percutaneous trans luminal angioplasty (PTA) as the only treatment option and a short lifetime. Little do we know of how to improve the survival of the AVF.

With this study we want to explore the effect of far infrared therapy on the stenosis, maturation and survival of the arteriovenous fistula.

The investigators will divide the patients into 2 groups: A treatment group and a control group.

The treatment group will receive infrared therapy on their fistula during their dialysis session. The control group will not receive any infrared therapy.

The investigators hope to reduce the risk of stenosis in the fistula and improve the fistula survival with this treatment.

Furthermore, the investigators want to explore the change in several biochemical markers during the treatment with infrared therapy.

Conditions

  • Arterio-venous Fistula

Interventions

RADIATION

Far infrared radiation

The treatment group will receive FIR for 40 minutes on the skin above the fistula during each dialysis session for one year.

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    collaborator OTHER

  • Hillerod Hospital, Denmark

    collaborator OTHER

  • Holbaek Sygehus

    collaborator OTHER

  • Zealand University Hospital

    collaborator OTHER

  • Herlev and Gentofte Hospital

    lead OTHER

Principal Investigators

  • Ditte Hansen, Doctor · Herlev Hospital, Department of Nephrology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-03
Primary Completion
2023-08-29
Completion
2023-08-29

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04011072 on ClinicalTrials.gov